Pages that link to "Q58862200"

The following pages link to Association among ORMDL3 gene expression, 17q21 polymorphism and response to treatment with inhaled corticosteroids in children with asthma (Q58862200):

Displaying 27 items.

• Signal transducer and activator of transcription 6 directly regulates human ORMDL3 expression (Q24323001) (← links)
• Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies (Q28067073) (← links)
• Research advances in gene polymorphisms in biological pathways of drugs for asthma (Q28079307) (← links)
• The Immunogenetics of Autoimmune Cholestasis (Q28085346) (← links)
• Risk of childhood asthma is associated with CpG-site polymorphisms, regional DNA methylation and mRNA levels at the GSDMB/ORMDL3 locus (Q34920713) (← links)
• Genetics of allergic diseases (Q35556785) (← links)
• Role of DNA methylation in expression control of the IKZF3-GSDMA region in human epithelial cells (Q36291642) (← links)
• CMTR1 is associated with increased asthma exacerbations in patients taking inhaled corticosteroids (Q36410606) (← links)
• Pharmacogenetics and the development of personalized approaches for combination therapy in asthma (Q37425660) (← links)
• Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium (Q38668126) (← links)
• The role of ORMDL proteins, guardians of cellular sphingolipids, in asthma (Q38771128) (← links)
• E3 ubiquitin ligase Cbl-b suppresses human ORMDL3 expression through STAT6 mediation (Q38859990) (← links)
• PTGDR gene expression and response to dexamethasone treatment in an in vitro model. (Q47162654) (← links)
• Effects of genetic factors to inhaled corticosteroid response in children with asthma: a literature review (Q47678283) (← links)
• Pharmacogenetic and pharmacogenomic considerations of asthma treatment. (Q48220346) (← links)
• Polymorphisms in recent GWA identified asthma genes CA10, SGK493, and CTNNA3 are associated with disease severity and treatment response in childhood asthma. (Q54385444) (← links)
• Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology? (Q55501424) (← links)
• 17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use (Q57637870) (← links)
• The ORMDL3 Asthma Gene Regulates ICAM1 and has Multiple Effects on Cellular Inflammation (Q58585970) (← links)
• Genetic associations of the response to inhaled corticosteroids in asthma: a systematic review (Q60913194) (← links)
• Asthma and obesity in the Middle East region: An overview (Q64088374) (← links)
• Pharmacogenetic Factors Affecting Asthma Treatment Response. Potential Implications for Drug Therapy. (Q64923655) (← links)
• ORMDL3 but not neighboring 17q21 gene LRRC3C is expressed in human lungs and lung cells of asthmatics (Q89839649) (← links)
• Genome-wide interaction study reveals age-dependent determinants of responsiveness to inhaled corticosteroids in individuals with asthma (Q89972197) (← links)
• Pharmacogenetics of Pediatric Asthma: Current Perspectives (Q91633083) (← links)
• Childhood asthma in the new omics era: challenges and perspectives (Q92963579) (← links)
• Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy (Q93009686) (← links)